Subramaniam Narayana, Balasubramanian Deepak, Murthy Samskruthi, Limbachiya Shashikant, Thankappan Krishnakumar, Iyer Subramania
Senior Resident, Head and Neck Oncology, Amrita Institute of Medical Sciences, AIMS Road, Kochi, Kerala, India.
Assistant Professor, Head and Neck Oncology, Kochi, Kerala, India.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jul;124(1):24-31. doi: 10.1016/j.oooo.2017.03.002. Epub 2017 Mar 10.
The use of postoperative radiotherapy (PORT) in early stage oral cancer with adverse pathologic features (APFs) is controversial. Prognostically relevant APFs reviewed were perineural invasion, lymphovascular invasion, depth of invasion, worst pattern of invasion, and margin status. The current literature remains divided with regard to the benefit of treatment escalation in these patients; although these patients are at high risk for recurrence, the morbidity of PORT needs to be balanced against the likely benefit in disease control. A wide heterogeneity in the literature exists, likely as a result of differences in treatment protocols. We performed a literature review of the role of PORT in early-stage oral cancer with APFs. Based on the current evidence, the decision to administer adjuvant therapy needs to be made on an individual basis; patients with >1 APF are likely to benefit from PORT, and the use of risk-scoring systems may help in decision making.
术后放疗(PORT)在具有不良病理特征(APF)的早期口腔癌中的应用存在争议。所回顾的与预后相关的APF包括神经周围浸润、脉管浸润、浸润深度、最差浸润模式和切缘状态。目前的文献对于这些患者治疗升级的益处仍存在分歧;尽管这些患者复发风险高,但PORT的发病率需要与疾病控制方面可能的益处相权衡。文献中存在广泛的异质性,这可能是治疗方案不同所致。我们对PORT在具有APF的早期口腔癌中的作用进行了文献综述。基于目前的证据,辅助治疗的决策需要个体化做出;具有超过1个APF的患者可能从PORT中获益,风险评分系统的使用可能有助于决策。